Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: TEP SNORD12B, SNORA63, and SNORD14E as novel biomarkers for hepatitis B virus-related hepatocellular carcinoma (HBV-related HCC)

Fig. 3

TEP SNORD12B, SNORA63, and SNORD14E can be used as neoteric diagnostic biomarkers for early-stage HBV-related HCC. (A) Differential expression of TEP SNORD12B, SNORD14E, and SNORA63 in healthy donors and patients with early-stage HBV-related HCC. (B) The AUCs of TEP SNORD12B, SNORA63, and SNORD14E in early HBV-associated HCC was 0.8386, 0.6709, and 0.6826, respectively. (C) The diagnostic performance of the three TEP snoRNAs combined showed an AUC of 0.9267. (AUC: area under curve. ***p < 0.001, ****p < 0.0001)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us